Related Experiment Videos

Nontransplant surgical interventions in progressive familial intrahepatic cholestasis

Adam Rahn Davis1, Philip Rosenthal, Thomas B Newman

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of California, San Francisco, CA 94143, USA. davisa@peds.ucsf.edu

Insights

Nontransplant surgery offers successful outcomes for most Progressive Familial Intrahepatic Cholestasis (PFIC) patients, halting disease progression. Further research and standardized outcome measurements are needed to compare surgical techniques for this rare childhood liver disease.

Area of Science:

  • Hepatology
  • Pediatric Surgery
  • Medical Genetics

Background:

  • Progressive Familial Intrahepatic Cholestasis (PFIC) comprises rare, fatal childhood liver diseases.
  • Liver transplantation was the only cure until nontransplant surgical interventions became standard care.
  • Various surgical techniques exist, but outcomes have not been systematically reviewed.

Purpose of the Study:

  • To review the outcomes of nontransplant surgical interventions in patients with PFIC.
  • To identify trends and success rates of current surgical approaches for PFIC.

Main Methods:

  • Systematic literature search for studies on nontransplant surgical interventions in PFIC.
  • Abstraction and summarization of data from case series and case reports.

Main Results:

  • No clinical trials were identified; analysis included 11 case series/reports.
  • Nontransplant surgery demonstrated an 81% success rate, halting disease progression and resolving symptoms.
  • Treatment failures were linked to advanced stages of the disease.

Conclusions:

  • No single nontransplant surgical intervention is proven superior for PFIC.
  • A patient registry and standardized outcome metrics are proposed for better comparative analysis.
Abstract